Connection

David Morrow to Receptor, PAR-1

Back to Details
This is a "connection" page, showing publications David Morrow has written about Receptor, PAR-1.
David Morrow
Connection Strength
0.049
Receptor, PAR-1
  1. Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function. J Thromb Thrombolysis. 2019 Apr; 47(3):353-360.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.